TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -27.30%52.51M | ---- | -13.17%72.23M | ---- | -5.26%83.18M | ---- | 32.58%87.8M | ---- | 36.44%66.22M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 212.38%17.99M | ---- | --5.76M | ---- | ---- | ---- | ---- | ---- | ---- |
Interest expense - adjustment | ---- | -9.37%18.91M | ---- | -1.13%20.87M | ---- | -17.79%21.11M | ---- | -26.94%25.68M | ---- | 1.43%35.15M |
Attributable subsidiary (profit) loss | ---- | -47.62%22K | ---- | --42K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | --0 | ---- | ---- | ---- | 372.06%6.51M | ---- | -120.36%-2.39M | ---- | -30.30%11.76M |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | 372.06%6.51M | ---- | -120.36%-2.39M | ---- | -30.30%11.76M |
Revaluation surplus: | ---- | -43.42%4.6M | ---- | 190.53%8.13M | ---- | -1,007.07%-8.98M | ---- | -86.51%990K | ---- | 458.17%7.34M |
-Fair value of investment properties (increase) | ---- | -43.42%4.6M | ---- | 190.53%8.13M | ---- | -1,007.07%-8.98M | ---- | -86.51%990K | ---- | 392.62%7.34M |
Asset sale loss (gain): | ---- | ---240K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---14.16M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---14.16M |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---240K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 7.76%3.1M | ---- | -4.52%2.87M | ---- | -0.13%3.01M | ---- | -0.33%3.01M | ---- | 2.68%3.02M |
-Depreciation | ---- | 7.76%3.1M | ---- | -4.52%2.87M | ---- | -0.13%3.01M | ---- | -0.33%3.01M | ---- | 2.68%3.02M |
Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.52%7.4M |
Operating profit before the change of operating capital | ---- | -11.84%96.89M | ---- | 4.83%109.9M | ---- | -8.91%104.83M | ---- | -1.41%115.08M | ---- | 4.08%116.72M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | -127.43%-14.08M | ---- | --51.31M | ---- | ---- | ---- | ---- | ---- | ---- |
Accounts payable increase (decrease) | ---- | -68,350.00%-2.74M | ---- | -100.23%-4K | ---- | 22.05%1.78M | ---- | 299.73%1.46M | ---- | 59.39%-729K |
prepayments (increase)decrease | ---- | -155.63%-1.82M | ---- | -358.06%-710K | ---- | -101.00%-155K | ---- | 2,077.39%15.48M | ---- | -184.01%-783K |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | -176.41%-92.97M | ---- | 219.88%121.68M | ---- | -58.63%-101.5M |
Cash from business operations | 17.83%73.29M | -61.69%61.49M | -32.11%62.2M | 1,784.66%160.5M | 638.00%91.62M | -96.69%8.52M | -110.64%-17.03M | 1,515.11%257.51M | 12,303.36%159.99M | -63.16%15.94M |
Hong Kong profits tax paid | ---- | -40.80%-13.62M | ---- | 56.76%-9.67M | ---- | -85.25%-22.36M | ---- | -1,974.05%-12.07M | ---- | 91.26%-582K |
Other taxs | -27.46%-2.02M | ---- | ---1.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Interest received - operating | ---- | ---- | ---- | ---- | ---- | -230.24%-4.97M | ---- | 70.60%3.81M | ---- | 155.64%2.24M |
Interest paid - operating | 14.56%-9.16M | 8.98%-18.91M | -6.69%-10.72M | -3.86%-20.78M | 1.73%-10.05M | 17.92%-20.01M | 20.70%-10.22M | 27.98%-24.38M | 22.31%-12.89M | -1.79%-33.85M |
Special items of business | ---- | ---- | ---- | ---- | ---- | 230.24%4.97M | ---- | -70.60%-3.81M | ---- | -155.64%-2.24M |
Net cash from operations | 24.48%62.11M | -77.73%28.96M | -38.83%49.9M | 484.13%130.05M | 399.32%81.58M | -115.31%-33.86M | -118.53%-27.25M | 1,295.78%221.06M | 921.58%147.1M | -648.58%-18.49M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | --1.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | --240K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | -7,930.00%-3.21M | -619.14%-2.18M | 76.74%-40K | 73.14%-303K | 80.30%-172K | 43.00%-1.13M | -44.30%-873K | -714.40%-1.98M | -275.78%-605K | 51.98%-243K |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --25.46M |
Cash on investment | ---- | ---- | ---- | 50.00%-14M | ---14M | ---28M | ---- | ---- | ---- | ---- |
Net cash from investment operations | -7,930.00%-3.21M | 99.03%-139K | 99.72%-40K | 50.90%-14.3M | -1,523.37%-14.17M | -1,371.85%-29.13M | -44.30%-873K | -107.85%-1.98M | -275.78%-605K | 5,084.19%25.22M |
Net cash before financing | 18.14%58.9M | -75.10%28.82M | -26.03%49.86M | 283.77%115.74M | 339.65%67.4M | -128.75%-62.98M | -119.20%-28.13M | 3,153.90%219.09M | 910.91%146.49M | 135.09%6.73M |
Cash flow from financing activities | ||||||||||
New borrowing | -87.25%80M | -68.49%289.49M | -2.98%627.55M | -14.83%918.82M | 31.92%646.82M | 72.84%1.08B | -26.18%490.3M | -54.37%624.15M | 6.41%664.15M | -4.35%1.37B |
Refund | 80.68%-128.26M | 72.19%-273.25M | -5.91%-663.83M | -2.13%-982.51M | -28.31%-626.81M | -24.90%-962.06M | 39.78%-488.52M | 45.19%-770.3M | -26.98%-811.22M | -1.00%-1.41B |
Dividends paid - financing | ---- | 0.00%-10.79M | ---- | 0.00%-10.79M | ---- | 0.00%-10.79M | ---- | 0.00%-10.79M | ---- | -8.33%-10.79M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 70.89%-23M | ---23M | ---79M | ---- | ---- | ---- | ---- |
Other items of the financing business | -300.00%-7M | -169.49%-35.77M | -330.13%-1.75M | 30.51%-13.27M | 104.15%760K | -836.31%-19.1M | ---18.32M | -86.85%2.59M | ---- | 205.13%19.72M |
Net cash from financing operations | -45.30%-55.26M | 72.62%-30.32M | -1,609.08%-38.03M | -1,512.28%-110.75M | 86.55%-2.23M | 105.08%7.84M | 88.76%-16.54M | -436.88%-154.34M | -5,392.30%-147.07M | -4,092.78%-28.75M |
Net Cash | -69.19%3.64M | -130.02%-1.5M | -81.85%11.83M | 109.05%4.99M | 245.93%65.18M | -185.17%-55.14M | -7,561.06%-44.66M | 394.09%64.74M | 96.19%-583K | -714.26%-22.02M |
Begining period cash | -5.02%28.38M | 20.07%29.88M | 20.07%29.88M | -68.91%24.88M | -68.91%24.88M | 423.75%80.02M | 423.75%80.02M | -59.03%15.28M | -59.03%15.28M | 10.63%37.29M |
Cash at the end | -23.22%32.02M | -5.02%28.38M | -53.69%41.7M | 20.07%29.88M | 154.70%90.06M | -68.91%24.88M | 140.60%35.36M | 423.75%80.02M | -33.22%14.7M | -59.03%15.28M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.